| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Aldosterone | 202 | 2024 | 875 | 13.110 |
Why?
|
| Hypertension | 196 | 2024 | 8611 | 6.760 |
Why?
|
| Angiotensin II | 184 | 2023 | 849 | 5.610 |
Why?
|
| Renin | 146 | 2024 | 642 | 5.090 |
Why?
|
| Sodium Chloride, Dietary | 29 | 2024 | 295 | 4.720 |
Why?
|
| Renin-Angiotensin System | 71 | 2019 | 735 | 4.390 |
Why?
|
| Sodium, Dietary | 42 | 2020 | 427 | 3.640 |
Why?
|
| Zona Glomerulosa | 28 | 2021 | 87 | 3.560 |
Why?
|
| Calmodulin-Binding Proteins | 11 | 2021 | 239 | 3.430 |
Why?
|
| Blood Pressure | 129 | 2024 | 8538 | 3.200 |
Why?
|
| Receptors, Mineralocorticoid | 24 | 2024 | 167 | 3.000 |
Why?
|
| Adrenal Glands | 62 | 2020 | 557 | 2.820 |
Why?
|
| Diet, Sodium-Restricted | 61 | 2023 | 291 | 2.350 |
Why?
|
| Angiotensinogen | 19 | 2021 | 161 | 2.170 |
Why?
|
| Sodium | 93 | 2024 | 1595 | 1.940 |
Why?
|
| Potassium | 81 | 2020 | 1319 | 1.860 |
Why?
|
| Spironolactone | 20 | 2024 | 412 | 1.860 |
Why?
|
| Hyperaldosteronism | 18 | 2020 | 250 | 1.630 |
Why?
|
| Caveolin 1 | 12 | 2020 | 255 | 1.540 |
Why?
|
| Histone Demethylases | 6 | 2020 | 322 | 1.460 |
Why?
|
| Nerve Tissue Proteins | 9 | 2021 | 4417 | 1.360 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 44 | 2019 | 1518 | 1.270 |
Why?
|
| Kidney | 56 | 2023 | 7064 | 1.270 |
Why?
|
| Renal Circulation | 36 | 2010 | 291 | 1.220 |
Why?
|
| Hydrocortisone | 55 | 2020 | 1836 | 1.130 |
Why?
|
| Weightlessness Simulation | 6 | 2006 | 41 | 1.080 |
Why?
|
| Endocrine System | 3 | 2019 | 113 | 1.050 |
Why?
|
| Renal Plasma Flow | 6 | 2021 | 27 | 1.050 |
Why?
|
| Insulin Resistance | 24 | 2018 | 3974 | 1.020 |
Why?
|
| Membrane Proteins | 9 | 2021 | 7895 | 1.020 |
Why?
|
| Antihypertensive Agents | 22 | 2013 | 2028 | 0.950 |
Why?
|
| Polymorphism, Single Nucleotide | 29 | 2024 | 16029 | 0.930 |
Why?
|
| Hypotension, Orthostatic | 7 | 2006 | 258 | 0.890 |
Why?
|
| Estrogen Receptor beta | 2 | 2021 | 172 | 0.860 |
Why?
|
| Thyrotropin | 4 | 2021 | 834 | 0.830 |
Why?
|
| Adrenocorticotropic Hormone | 44 | 2006 | 619 | 0.790 |
Why?
|
| Hypertension, Renal | 10 | 2021 | 135 | 0.770 |
Why?
|
| Enalapril | 14 | 2006 | 316 | 0.740 |
Why?
|
| Homeostasis | 23 | 2020 | 3351 | 0.730 |
Why?
|
| Cardiovascular System | 7 | 2015 | 838 | 0.660 |
Why?
|
| Vasoconstrictor Agents | 15 | 2015 | 658 | 0.660 |
Why?
|
| Rats, Wistar | 13 | 2023 | 1891 | 0.660 |
Why?
|
| Thyroid Gland | 3 | 2021 | 1172 | 0.620 |
Why?
|
| Captopril | 25 | 2013 | 262 | 0.610 |
Why?
|
| Adrenal Cortex | 12 | 2005 | 134 | 0.610 |
Why?
|
| Bed Rest | 10 | 2005 | 83 | 0.600 |
Why?
|
| Oxidoreductases, N-Demethylating | 3 | 2012 | 109 | 0.580 |
Why?
|
| Corticosterone | 22 | 2017 | 302 | 0.580 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 6 | 2023 | 3253 | 0.580 |
Why?
|
| Male | 271 | 2024 | 364781 | 0.580 |
Why?
|
| Hemodynamics | 20 | 2021 | 4202 | 0.570 |
Why?
|
| Myocardium | 9 | 2020 | 4788 | 0.570 |
Why?
|
| Zona Reticularis | 1 | 2017 | 8 | 0.570 |
Why?
|
| Endothelin-1 | 2 | 2017 | 302 | 0.560 |
Why?
|
| Signal Transduction | 19 | 2020 | 23638 | 0.560 |
Why?
|
| Hyperkalemia | 5 | 2016 | 233 | 0.550 |
Why?
|
| Genotype | 25 | 2024 | 13047 | 0.540 |
Why?
|
| Hypothyroidism | 2 | 2021 | 670 | 0.530 |
Why?
|
| Adult | 241 | 2024 | 223542 | 0.530 |
Why?
|
| Vasoconstriction | 11 | 2015 | 594 | 0.530 |
Why?
|
| Animals | 126 | 2023 | 169418 | 0.520 |
Why?
|
| Mineralocorticoids | 3 | 2012 | 37 | 0.510 |
Why?
|
| Humans | 395 | 2024 | 768451 | 0.510 |
Why?
|
| Heart | 5 | 2023 | 4451 | 0.510 |
Why?
|
| Middle Aged | 201 | 2024 | 223418 | 0.510 |
Why?
|
| Receptor, Angiotensin, Type 1 | 6 | 2024 | 153 | 0.500 |
Why?
|
| Sex Characteristics | 6 | 2021 | 2666 | 0.500 |
Why?
|
| Cardiovascular Deconditioning | 2 | 2005 | 9 | 0.480 |
Why?
|
| Female | 251 | 2024 | 396943 | 0.480 |
Why?
|
| Genetic Predisposition to Disease | 15 | 2021 | 18048 | 0.480 |
Why?
|
| Renal Insufficiency, Chronic | 2 | 2021 | 2291 | 0.480 |
Why?
|
| Calcium Channel Blockers | 8 | 2003 | 692 | 0.460 |
Why?
|
| Sodium Chloride | 19 | 2023 | 585 | 0.460 |
Why?
|
| TOR Serine-Threonine Kinases | 2 | 2024 | 2067 | 0.460 |
Why?
|
| Rats | 59 | 2023 | 23839 | 0.460 |
Why?
|
| Insulin | 21 | 2017 | 6606 | 0.450 |
Why?
|
| Caveolins | 1 | 2014 | 102 | 0.440 |
Why?
|
| NG-Nitroarginine Methyl Ester | 9 | 2023 | 262 | 0.430 |
Why?
|
| Cardiovascular Diseases | 11 | 2023 | 15638 | 0.430 |
Why?
|
| Haplotypes | 5 | 2012 | 2725 | 0.420 |
Why?
|
| Vesicovaginal Fistula | 1 | 2012 | 10 | 0.420 |
Why?
|
| Iodide Peroxidase | 2 | 2021 | 295 | 0.410 |
Why?
|
| Nitric Oxide Synthase Type III | 6 | 2013 | 706 | 0.410 |
Why?
|
| Angiotensin I | 6 | 2004 | 53 | 0.390 |
Why?
|
| Phenotype | 21 | 2023 | 16712 | 0.380 |
Why?
|
| Adaptation, Physiological | 4 | 2006 | 1315 | 0.380 |
Why?
|
| Pelvic Floor | 1 | 2012 | 138 | 0.370 |
Why?
|
| Calcium | 21 | 2012 | 5793 | 0.370 |
Why?
|
| Sex Factors | 16 | 2024 | 10647 | 0.370 |
Why?
|
| Albuminuria | 6 | 2019 | 658 | 0.370 |
Why?
|
| Polymorphism, Genetic | 13 | 2017 | 4249 | 0.350 |
Why?
|
| Glucocorticoids | 4 | 2012 | 2170 | 0.350 |
Why?
|
| Kidney Diseases | 4 | 2019 | 2102 | 0.350 |
Why?
|
| Mice, Knockout | 15 | 2020 | 14480 | 0.350 |
Why?
|
| Vasodilation | 9 | 2015 | 968 | 0.350 |
Why?
|
| Hypothalamo-Hypophyseal System | 10 | 2021 | 705 | 0.340 |
Why?
|
| Head-Down Tilt | 8 | 2006 | 67 | 0.340 |
Why?
|
| Joint Diseases | 1 | 2014 | 460 | 0.340 |
Why?
|
| Alleles | 9 | 2021 | 6890 | 0.330 |
Why?
|
| Heart Failure | 13 | 2023 | 11857 | 0.330 |
Why?
|
| Education, Graduate | 1 | 2010 | 75 | 0.330 |
Why?
|
| Posture | 25 | 2005 | 956 | 0.320 |
Why?
|
| Muscle, Smooth, Vascular | 7 | 2013 | 1494 | 0.320 |
Why?
|
| Polymers | 1 | 2016 | 1631 | 0.320 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 5 | 2008 | 280 | 0.310 |
Why?
|
| RNA, Messenger | 11 | 2023 | 12813 | 0.300 |
Why?
|
| Amlodipine | 4 | 2021 | 84 | 0.300 |
Why?
|
| Heart Diseases | 3 | 2019 | 2816 | 0.300 |
Why?
|
| Receptors, Angiotensin | 7 | 2001 | 141 | 0.300 |
Why?
|
| PPAR gamma | 2 | 2010 | 487 | 0.300 |
Why?
|
| Diltiazem | 5 | 1998 | 132 | 0.290 |
Why?
|
| Musculoskeletal Diseases | 1 | 2014 | 601 | 0.290 |
Why?
|
| Gene Expression Regulation | 6 | 2014 | 11930 | 0.280 |
Why?
|
| Nucleotides | 3 | 2024 | 455 | 0.280 |
Why?
|
| Cardiomegaly | 1 | 2010 | 591 | 0.280 |
Why?
|
| Atherosclerosis | 1 | 2023 | 3431 | 0.280 |
Why?
|
| Cushing Syndrome | 8 | 2020 | 241 | 0.280 |
Why?
|
| Weightlessness | 2 | 2005 | 102 | 0.270 |
Why?
|
| Blood Glucose | 21 | 2018 | 6429 | 0.270 |
Why?
|
| Immobilization | 2 | 2006 | 230 | 0.270 |
Why?
|
| Receptors, Adrenergic, beta-2 | 2 | 2010 | 217 | 0.270 |
Why?
|
| Postural Orthostatic Tachycardia Syndrome | 3 | 2012 | 52 | 0.270 |
Why?
|
| Teprotide | 16 | 1985 | 25 | 0.270 |
Why?
|
| Interleukin-6 | 3 | 2023 | 3234 | 0.260 |
Why?
|
| Rats, Inbred Strains | 17 | 1992 | 2087 | 0.260 |
Why?
|
| Hydroxysteroid Dehydrogenases | 2 | 1998 | 30 | 0.250 |
Why?
|
| Mice | 27 | 2021 | 82045 | 0.250 |
Why?
|
| Renal Artery | 5 | 2000 | 353 | 0.250 |
Why?
|
| Environment | 1 | 2011 | 1126 | 0.250 |
Why?
|
| Body Mass Index | 15 | 2012 | 13030 | 0.250 |
Why?
|
| Aerospace Medicine | 1 | 2006 | 95 | 0.250 |
Why?
|
| Caloric Restriction | 2 | 2018 | 300 | 0.250 |
Why?
|
| Dose-Response Relationship, Drug | 35 | 2013 | 10784 | 0.250 |
Why?
|
| Aged | 76 | 2024 | 171520 | 0.240 |
Why?
|
| Progesterone | 5 | 2010 | 750 | 0.240 |
Why?
|
| Radioimmunoassay | 21 | 2010 | 862 | 0.240 |
Why?
|
| Hypertrophy, Left Ventricular | 4 | 2005 | 857 | 0.240 |
Why?
|
| Sugar Phosphates | 3 | 1989 | 44 | 0.240 |
Why?
|
| Adolescent | 48 | 2024 | 89168 | 0.230 |
Why?
|
| Inositol Phosphates | 3 | 1989 | 175 | 0.230 |
Why?
|
| Angiotensins | 5 | 1991 | 141 | 0.230 |
Why?
|
| Atrial Fibrillation | 1 | 2023 | 5162 | 0.230 |
Why?
|
| Young Adult | 17 | 2024 | 60045 | 0.230 |
Why?
|
| Stroke | 3 | 2023 | 9791 | 0.230 |
Why?
|
| Nifedipine | 7 | 2000 | 220 | 0.220 |
Why?
|
| Cytosol | 7 | 1996 | 889 | 0.220 |
Why?
|
| Pituitary-Adrenal System | 10 | 2012 | 557 | 0.220 |
Why?
|
| Saralasin | 13 | 1989 | 34 | 0.220 |
Why?
|
| Myocardial Infarction | 4 | 2023 | 11515 | 0.220 |
Why?
|
| Dopamine | 9 | 1994 | 1616 | 0.220 |
Why?
|
| Glucose | 10 | 2016 | 4355 | 0.220 |
Why?
|
| Metoclopramide | 6 | 1990 | 51 | 0.220 |
Why?
|
| Water-Electrolyte Balance | 5 | 2019 | 326 | 0.210 |
Why?
|
| Genetic Variation | 4 | 2011 | 6610 | 0.210 |
Why?
|
| Verapamil | 6 | 2005 | 242 | 0.210 |
Why?
|
| Diabetes Mellitus, Type 2 | 12 | 2012 | 12242 | 0.210 |
Why?
|
| Sociology, Medical | 1 | 2003 | 62 | 0.210 |
Why?
|
| Estradiol | 6 | 2010 | 1949 | 0.210 |
Why?
|
| Receptors, Glucocorticoid | 2 | 2017 | 309 | 0.210 |
Why?
|
| Catecholamines | 5 | 2010 | 390 | 0.200 |
Why?
|
| Quality of Life | 14 | 2011 | 13497 | 0.200 |
Why?
|
| Hydrochlorothiazide | 6 | 2003 | 95 | 0.200 |
Why?
|
| Aorta | 6 | 2015 | 2046 | 0.190 |
Why?
|
| Secretory Pathway | 1 | 2021 | 53 | 0.190 |
Why?
|
| Cholesterol, LDL | 4 | 2020 | 2396 | 0.190 |
Why?
|
| Cells, Cultured | 16 | 2021 | 19041 | 0.190 |
Why?
|
| Proline | 9 | 1984 | 456 | 0.190 |
Why?
|
| Potassium Channels | 3 | 1992 | 538 | 0.190 |
Why?
|
| Aging | 8 | 2017 | 8761 | 0.190 |
Why?
|
| Infusions, Intravenous | 12 | 2012 | 2228 | 0.180 |
Why?
|
| Circadian Rhythm | 8 | 2003 | 2585 | 0.180 |
Why?
|
| Propranolol | 6 | 2011 | 493 | 0.180 |
Why?
|
| Cohort Studies | 12 | 2024 | 41797 | 0.180 |
Why?
|
| 17-Hydroxycorticosteroids | 17 | 1990 | 38 | 0.180 |
Why?
|
| Receptors, Cell Surface | 7 | 2011 | 2819 | 0.180 |
Why?
|
| Angiotensin II Type 1 Receptor Blockers | 3 | 2016 | 429 | 0.180 |
Why?
|
| Melatonin | 2 | 2003 | 669 | 0.180 |
Why?
|
| Thyroid Function Tests | 1 | 2021 | 289 | 0.180 |
Why?
|
| Chromatography, High Pressure Liquid | 9 | 2010 | 1543 | 0.180 |
Why?
|
| Adrenal Medulla | 3 | 1989 | 56 | 0.170 |
Why?
|
| Gene Frequency | 7 | 2016 | 3615 | 0.170 |
Why?
|
| Promoter Regions, Genetic | 1 | 2011 | 5803 | 0.170 |
Why?
|
| Renal Veins | 1 | 2000 | 103 | 0.170 |
Why?
|
| Diet | 25 | 2020 | 8098 | 0.170 |
Why?
|
| Linkage Disequilibrium | 4 | 2012 | 1998 | 0.170 |
Why?
|
| Hormones | 6 | 2014 | 870 | 0.170 |
Why?
|
| Natriuresis | 13 | 2003 | 105 | 0.160 |
Why?
|
| Age Factors | 16 | 2024 | 18478 | 0.160 |
Why?
|
| Oligopeptides | 8 | 1985 | 1193 | 0.160 |
Why?
|
| Risk Factors | 24 | 2023 | 74915 | 0.160 |
Why?
|
| Adiponectin | 4 | 2017 | 1118 | 0.160 |
Why?
|
| Aminopeptidases | 1 | 2019 | 113 | 0.160 |
Why?
|
| Norepinephrine | 9 | 2010 | 900 | 0.160 |
Why?
|
| Postmenopause | 4 | 2008 | 2519 | 0.160 |
Why?
|
| Biphenyl Compounds | 5 | 2008 | 1026 | 0.160 |
Why?
|
| Carrier Proteins | 7 | 2024 | 4948 | 0.160 |
Why?
|
| Muscle, Skeletal | 1 | 2014 | 4984 | 0.160 |
Why?
|
| Isradipine | 1 | 1998 | 12 | 0.160 |
Why?
|
| Estrogens | 7 | 2014 | 1531 | 0.150 |
Why?
|
| Atenolol | 3 | 2003 | 99 | 0.150 |
Why?
|
| Regional Blood Flow | 9 | 2017 | 1502 | 0.150 |
Why?
|
| Minor Histocompatibility Antigens | 1 | 2019 | 302 | 0.150 |
Why?
|
| Veins | 3 | 2011 | 767 | 0.150 |
Why?
|
| Double-Blind Method | 17 | 2020 | 12450 | 0.150 |
Why?
|
| Glycyrrhetinic Acid | 1 | 1998 | 15 | 0.150 |
Why?
|
| Kinetics | 21 | 1993 | 6348 | 0.150 |
Why?
|
| Tetrazoles | 5 | 2008 | 922 | 0.150 |
Why?
|
| Phosphatidylinositols | 2 | 1989 | 280 | 0.150 |
Why?
|
| Vasodilator Agents | 9 | 2011 | 991 | 0.150 |
Why?
|
| Ion Transport | 1 | 2018 | 322 | 0.140 |
Why?
|
| Prostaglandins | 6 | 1984 | 398 | 0.140 |
Why?
|
| Sulfones | 1 | 2020 | 448 | 0.140 |
Why?
|
| Resistin | 3 | 2016 | 172 | 0.140 |
Why?
|
| Cyclic GMP | 3 | 2015 | 395 | 0.140 |
Why?
|
| Education, Medical, Graduate | 1 | 2010 | 2411 | 0.140 |
Why?
|
| Sleep Deprivation | 1 | 2004 | 848 | 0.140 |
Why?
|
| Fasting | 4 | 2011 | 1608 | 0.140 |
Why?
|
| Reference Values | 15 | 2010 | 4941 | 0.140 |
Why?
|
| Meniere Disease | 1 | 2018 | 164 | 0.140 |
Why?
|
| Enzyme Inhibitors | 8 | 2015 | 3734 | 0.140 |
Why?
|
| p-Aminohippuric Acid | 10 | 2014 | 36 | 0.140 |
Why?
|
| Sympathetic Nervous System | 5 | 2010 | 521 | 0.140 |
Why?
|
| Pregnancy Complications, Cardiovascular | 3 | 1993 | 518 | 0.140 |
Why?
|
| Sirolimus | 1 | 2024 | 1542 | 0.140 |
Why?
|
| Desoxycorticosterone | 7 | 1979 | 46 | 0.130 |
Why?
|
| Baroreflex | 2 | 2012 | 154 | 0.130 |
Why?
|
| Time Factors | 36 | 2020 | 40271 | 0.130 |
Why?
|
| Antiporters | 3 | 1999 | 277 | 0.130 |
Why?
|
| Hypoventilation | 1 | 2016 | 44 | 0.130 |
Why?
|
| Kallikreins | 5 | 2010 | 221 | 0.130 |
Why?
|
| Cross-Sectional Studies | 10 | 2021 | 26351 | 0.130 |
Why?
|
| Dipeptides | 6 | 1994 | 386 | 0.130 |
Why?
|
| Lipid Metabolism | 2 | 2016 | 1898 | 0.130 |
Why?
|
| Nitric Oxide | 3 | 2015 | 2146 | 0.130 |
Why?
|
| Vascular Resistance | 5 | 2005 | 941 | 0.130 |
Why?
|
| Genetic Association Studies | 4 | 2017 | 2742 | 0.130 |
Why?
|
| Sleep Apnea, Central | 1 | 2016 | 88 | 0.120 |
Why?
|
| Dyslipidemias | 2 | 2020 | 874 | 0.120 |
Why?
|
| Leg | 3 | 2005 | 1089 | 0.120 |
Why?
|
| Parathyroid Hormone | 3 | 2013 | 1804 | 0.120 |
Why?
|
| Hyperlipidemias | 1 | 2020 | 773 | 0.120 |
Why?
|
| Pressoreceptors | 2 | 1994 | 99 | 0.120 |
Why?
|
| Psychological Tests | 2 | 1997 | 643 | 0.120 |
Why?
|
| 18-Hydroxydesoxycorticosterone | 3 | 1979 | 3 | 0.120 |
Why?
|
| Ear, Inner | 1 | 2018 | 426 | 0.120 |
Why?
|
| Prostaglandins E | 5 | 1984 | 166 | 0.120 |
Why?
|
| Endorphins | 2 | 1985 | 74 | 0.120 |
Why?
|
| Erythrocytes | 5 | 1999 | 2422 | 0.120 |
Why?
|
| Midodrine | 2 | 2006 | 24 | 0.110 |
Why?
|
| Diabetes Mellitus | 5 | 2016 | 5887 | 0.110 |
Why?
|
| Fludrocortisone | 2 | 2012 | 24 | 0.110 |
Why?
|
| Pyrroles | 1 | 2020 | 1127 | 0.110 |
Why?
|
| Arginine Vasopressin | 2 | 1991 | 126 | 0.110 |
Why?
|
| Adrenergic beta-Antagonists | 4 | 2011 | 1244 | 0.110 |
Why?
|
| Potassium, Dietary | 2 | 2012 | 103 | 0.110 |
Why?
|
| Steroid Hydroxylases | 1 | 1993 | 93 | 0.110 |
Why?
|
| Estrogen Replacement Therapy | 3 | 2008 | 1209 | 0.110 |
Why?
|
| Digoxin | 5 | 1994 | 246 | 0.110 |
Why?
|
| Patient Compliance | 4 | 2005 | 2696 | 0.110 |
Why?
|
| Receptors, Gastrointestinal Hormone | 2 | 2010 | 44 | 0.110 |
Why?
|
| Ouabain | 3 | 1998 | 246 | 0.110 |
Why?
|
| Gene Expression | 4 | 2021 | 7605 | 0.110 |
Why?
|
| Genome-Wide Association Study | 9 | 2012 | 12774 | 0.110 |
Why?
|
| Adipokines | 2 | 2012 | 309 | 0.100 |
Why?
|
| Saponins | 4 | 1994 | 47 | 0.100 |
Why?
|
| Genetic Markers | 2 | 2011 | 2604 | 0.100 |
Why?
|
| Family Health | 3 | 2003 | 1256 | 0.100 |
Why?
|
| Hypoaldosteronism | 1 | 1992 | 7 | 0.100 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 5 | 1998 | 478 | 0.100 |
Why?
|
| Muscle Relaxation | 2 | 2010 | 138 | 0.100 |
Why?
|
| Diabetic Nephropathies | 4 | 2006 | 975 | 0.100 |
Why?
|
| Blood Volume | 6 | 2004 | 546 | 0.100 |
Why?
|
| Hyperuricemia | 2 | 2006 | 223 | 0.100 |
Why?
|
| Clinical Trials as Topic | 9 | 2021 | 8051 | 0.100 |
Why?
|
| Eclampsia | 1 | 1993 | 60 | 0.100 |
Why?
|
| Kidney Glomerulus | 2 | 2003 | 569 | 0.100 |
Why?
|
| Disease Models, Animal | 9 | 2018 | 18388 | 0.100 |
Why?
|
| Periodicity | 3 | 2004 | 348 | 0.100 |
Why?
|
| Bradykinin | 11 | 1983 | 205 | 0.100 |
Why?
|
| Depression, Postpartum | 1 | 1997 | 355 | 0.100 |
Why?
|
| Peptidyl-Dipeptidase A | 3 | 2006 | 330 | 0.100 |
Why?
|
| Genetic Loci | 3 | 2010 | 2630 | 0.100 |
Why?
|
| Cattle | 9 | 1995 | 3830 | 0.100 |
Why?
|
| Endocrine System Diseases | 1 | 1994 | 250 | 0.100 |
Why?
|
| Fumarates | 1 | 2012 | 132 | 0.100 |
Why?
|
| Edema | 2 | 2010 | 766 | 0.100 |
Why?
|
| Cyclic AMP | 2 | 1986 | 1468 | 0.090 |
Why?
|
| Feedback | 6 | 2001 | 794 | 0.090 |
Why?
|
| Blotting, Western | 3 | 2014 | 5042 | 0.090 |
Why?
|
| Endocrine Glands | 3 | 2004 | 101 | 0.090 |
Why?
|
| Triglycerides | 6 | 2016 | 2465 | 0.090 |
Why?
|
| Hydroxycholecalciferols | 1 | 2011 | 44 | 0.090 |
Why?
|
| Drug Therapy, Combination | 7 | 2008 | 6320 | 0.090 |
Why?
|
| Obesity | 7 | 2012 | 13065 | 0.090 |
Why?
|
| Adrenergic Fibers | 1 | 2010 | 21 | 0.090 |
Why?
|
| Affective Disorders, Psychotic | 1 | 2012 | 187 | 0.090 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 1993 | 423 | 0.090 |
Why?
|
| Gene Expression Profiling | 2 | 2010 | 9507 | 0.090 |
Why?
|
| Quantitative Trait, Heritable | 2 | 2011 | 540 | 0.090 |
Why?
|
| Diabetes Mellitus, Experimental | 2 | 2008 | 1121 | 0.090 |
Why?
|
| Adrenal Gland Neoplasms | 8 | 1980 | 736 | 0.090 |
Why?
|
| Cortodoxone | 2 | 1990 | 18 | 0.090 |
Why?
|
| Case-Control Studies | 10 | 2012 | 22293 | 0.090 |
Why?
|
| Methyldopa | 2 | 1987 | 18 | 0.090 |
Why?
|
| Enzyme Precursors | 3 | 2001 | 168 | 0.090 |
Why?
|
| Phosphorylation | 2 | 2019 | 8332 | 0.090 |
Why?
|
| Calcifediol | 1 | 2011 | 160 | 0.090 |
Why?
|
| Kinins | 5 | 2004 | 14 | 0.090 |
Why?
|
| Amides | 1 | 2012 | 452 | 0.080 |
Why?
|
| Predictive Value of Tests | 7 | 2012 | 15460 | 0.080 |
Why?
|
| Health Status | 1 | 2003 | 4096 | 0.080 |
Why?
|
| Random Allocation | 5 | 2021 | 2399 | 0.080 |
Why?
|
| Multivariate Analysis | 5 | 2017 | 12096 | 0.080 |
Why?
|
| Uric Acid | 2 | 2006 | 807 | 0.080 |
Why?
|
| Mice, Inbred C57BL | 5 | 2019 | 22365 | 0.080 |
Why?
|
| Adrenal Gland Diseases | 2 | 1980 | 141 | 0.080 |
Why?
|
| Down-Regulation | 1 | 2016 | 2944 | 0.080 |
Why?
|
| Diagnostic Errors | 1 | 2016 | 1282 | 0.080 |
Why?
|
| Glucose Clamp Technique | 3 | 2001 | 263 | 0.080 |
Why?
|
| Depressive Disorder, Major | 4 | 2012 | 4816 | 0.080 |
Why?
|
| Creatinine | 13 | 2008 | 1915 | 0.080 |
Why?
|
| Receptors, Calcitriol | 1 | 2011 | 361 | 0.080 |
Why?
|
| Meta-Analysis as Topic | 5 | 2012 | 1364 | 0.080 |
Why?
|
| Tryptophan | 1 | 2010 | 483 | 0.080 |
Why?
|
| Hypertriglyceridemia | 3 | 2016 | 293 | 0.080 |
Why?
|
| Thrombosis | 2 | 2021 | 2956 | 0.080 |
Why?
|
| Epoprostenol | 3 | 1986 | 248 | 0.080 |
Why?
|
| Glomerular Filtration Rate | 10 | 2014 | 2226 | 0.080 |
Why?
|
| Receptors, Estrogen | 2 | 2014 | 2243 | 0.080 |
Why?
|
| Analysis of Variance | 9 | 2006 | 6242 | 0.080 |
Why?
|
| Models, Animal | 4 | 2011 | 2126 | 0.080 |
Why?
|
| Heart Rate | 8 | 2011 | 4218 | 0.070 |
Why?
|
| Imidazoles | 1 | 1994 | 1174 | 0.070 |
Why?
|
| Calcium Channels | 1 | 1992 | 624 | 0.070 |
Why?
|
| Platelet Aggregation | 2 | 1988 | 772 | 0.070 |
Why?
|
| Epigenomics | 1 | 2014 | 956 | 0.070 |
Why?
|
| Drug Synergism | 6 | 2003 | 1765 | 0.070 |
Why?
|
| Lipids | 2 | 1996 | 3346 | 0.070 |
Why?
|
| Genetics, Medical | 1 | 2010 | 334 | 0.070 |
Why?
|
| Cholesterol | 5 | 2020 | 2910 | 0.070 |
Why?
|
| Plethysmography | 2 | 2005 | 174 | 0.070 |
Why?
|
| Drug Tolerance | 5 | 2004 | 367 | 0.070 |
Why?
|
| Arginine | 2 | 2010 | 923 | 0.070 |
Why?
|
| Corticotropin-Releasing Hormone | 3 | 1999 | 359 | 0.070 |
Why?
|
| Nitric Oxide Synthase | 1 | 2010 | 911 | 0.070 |
Why?
|
| Addison Disease | 3 | 1984 | 48 | 0.070 |
Why?
|
| Natriuretic Agents | 1 | 1987 | 57 | 0.070 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2011 | 703 | 0.070 |
Why?
|
| Vasomotor System | 2 | 2004 | 208 | 0.070 |
Why?
|
| Linear Models | 6 | 2017 | 5880 | 0.070 |
Why?
|
| Body Weight | 11 | 2008 | 4630 | 0.070 |
Why?
|
| Menstrual Cycle | 1 | 2010 | 542 | 0.070 |
Why?
|
| Prevalence | 2 | 2020 | 15880 | 0.070 |
Why?
|
| Exons | 1 | 2012 | 2392 | 0.070 |
Why?
|
| Adrenal Cortex Hormones | 3 | 1999 | 1891 | 0.070 |
Why?
|
| 6-Ketoprostaglandin F1 alpha | 2 | 1983 | 80 | 0.060 |
Why?
|
| Arteries | 1 | 2011 | 1126 | 0.060 |
Why?
|
| Pregnenolone | 3 | 1996 | 27 | 0.060 |
Why?
|
| C-Reactive Protein | 3 | 2023 | 3854 | 0.060 |
Why?
|
| Epigenesis, Genetic | 3 | 2020 | 3826 | 0.060 |
Why?
|
| Hyponatremia | 4 | 1984 | 281 | 0.060 |
Why?
|
| Infusions, Parenteral | 10 | 1997 | 398 | 0.060 |
Why?
|
| Hyperglycemia | 2 | 2013 | 1389 | 0.060 |
Why?
|
| Serum Albumin | 1 | 2009 | 676 | 0.060 |
Why?
|
| 11-beta-Hydroxysteroid Dehydrogenases | 2 | 1998 | 5 | 0.060 |
Why?
|
| Cholesterol, HDL | 3 | 2012 | 1820 | 0.060 |
Why?
|
| Stimulation, Chemical | 9 | 2010 | 306 | 0.060 |
Why?
|
| Diabetes Mellitus, Type 1 | 3 | 2006 | 3440 | 0.060 |
Why?
|
| Syncope | 2 | 2005 | 430 | 0.060 |
Why?
|
| Sodium Chloride Symporter Inhibitors | 2 | 2003 | 78 | 0.060 |
Why?
|
| Rats, Sprague-Dawley | 6 | 2000 | 8201 | 0.060 |
Why?
|
| Polymerase Chain Reaction | 1 | 2014 | 6091 | 0.060 |
Why?
|
| Chronobiology Disorders | 1 | 2006 | 73 | 0.060 |
Why?
|
| Fura-2 | 3 | 1990 | 107 | 0.060 |
Why?
|
| Specialization | 1 | 2010 | 782 | 0.060 |
Why?
|
| Molecular Sequence Data | 3 | 2010 | 17647 | 0.060 |
Why?
|
| Forearm | 1 | 2007 | 428 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 14 | 1 | 2005 | 286 | 0.060 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2006 | 474 | 0.060 |
Why?
|
| Blood Proteins | 4 | 1994 | 1183 | 0.060 |
Why?
|
| Metabolic Clearance Rate | 7 | 1992 | 363 | 0.060 |
Why?
|
| Gene Dosage | 1 | 2009 | 1221 | 0.060 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2006 | 478 | 0.060 |
Why?
|
| Benzofurans | 3 | 1990 | 139 | 0.060 |
Why?
|
| Acromegaly | 3 | 1980 | 316 | 0.060 |
Why?
|
| Glucose Tolerance Test | 3 | 2012 | 1181 | 0.060 |
Why?
|
| Exercise Therapy | 1 | 2011 | 941 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 2005 | 410 | 0.060 |
Why?
|
| F2-Isoprostanes | 1 | 2003 | 35 | 0.060 |
Why?
|
| Potassium Chloride | 4 | 1997 | 229 | 0.060 |
Why?
|
| Randomized Controlled Trials as Topic | 4 | 2020 | 10358 | 0.060 |
Why?
|
| 3',5'-Cyclic-AMP Phosphodiesterases | 1 | 1983 | 50 | 0.060 |
Why?
|
| Program Development | 1 | 2010 | 1296 | 0.050 |
Why?
|
| Quantitative Trait Loci | 3 | 2010 | 2127 | 0.050 |
Why?
|
| Pre-Eclampsia | 1 | 1993 | 1257 | 0.050 |
Why?
|
| Selective Estrogen Receptor Modulators | 1 | 2004 | 131 | 0.050 |
Why?
|
| Stress, Psychological | 1 | 1999 | 4538 | 0.050 |
Why?
|
| History, 16th Century | 1 | 2003 | 70 | 0.050 |
Why?
|
| Career Choice | 1 | 2010 | 769 | 0.050 |
Why?
|
| Growth Hormone | 6 | 1993 | 573 | 0.050 |
Why?
|
| Apolipoproteins C | 1 | 2003 | 59 | 0.050 |
Why?
|
| Up-Regulation | 2 | 2011 | 4138 | 0.050 |
Why?
|
| Rats, Inbred WKY | 3 | 1993 | 150 | 0.050 |
Why?
|
| Supine Position | 2 | 2001 | 208 | 0.050 |
Why?
|
| Reactive Oxygen Species | 2 | 2014 | 2150 | 0.050 |
Why?
|
| Cholesterol, VLDL | 1 | 2003 | 70 | 0.050 |
Why?
|
| Tetraethylammonium Compounds | 2 | 1992 | 31 | 0.050 |
Why?
|
| Tetraethylammonium | 2 | 1992 | 55 | 0.050 |
Why?
|
| Amniotic Fluid | 1 | 1984 | 381 | 0.050 |
Why?
|
| Blood Platelets | 2 | 1984 | 2485 | 0.050 |
Why?
|
| Calmodulin | 1 | 1983 | 241 | 0.050 |
Why?
|
| Estrogens, Conjugated (USP) | 1 | 2004 | 277 | 0.050 |
Why?
|
| Phenylephrine | 2 | 2015 | 294 | 0.050 |
Why?
|
| Kidney Failure, Chronic | 4 | 1994 | 2489 | 0.050 |
Why?
|
| Indomethacin | 4 | 1984 | 323 | 0.050 |
Why?
|
| Calcium Channels, L-Type | 1 | 2023 | 242 | 0.050 |
Why?
|
| Inflammation | 3 | 2012 | 10865 | 0.050 |
Why?
|
| 17-Ketosteroids | 12 | 1977 | 36 | 0.050 |
Why?
|
| Motor Activity | 1 | 2012 | 2722 | 0.050 |
Why?
|
| Guanylate Cyclase | 2 | 2013 | 206 | 0.050 |
Why?
|
| Space Simulation | 1 | 2001 | 9 | 0.050 |
Why?
|
| Magnesium | 3 | 1992 | 816 | 0.050 |
Why?
|
| Disease Susceptibility | 2 | 2004 | 1797 | 0.050 |
Why?
|
| Skin Diseases | 1 | 2010 | 1099 | 0.050 |
Why?
|
| Medicine | 1 | 2010 | 946 | 0.050 |
Why?
|
| Immunoradiometric Assay | 1 | 2001 | 20 | 0.050 |
Why?
|
| Membrane Potentials | 3 | 1992 | 1090 | 0.050 |
Why?
|
| Thyroxine | 3 | 2004 | 666 | 0.050 |
Why?
|
| Epistasis, Genetic | 1 | 2003 | 352 | 0.050 |
Why?
|
| Electrophysiology | 3 | 1992 | 1266 | 0.050 |
Why?
|
| Pravastatin | 1 | 2023 | 393 | 0.050 |
Why?
|
| Confidence Intervals | 1 | 2006 | 2932 | 0.050 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2016 | 4586 | 0.050 |
Why?
|
| Ovariectomy | 2 | 2008 | 614 | 0.050 |
Why?
|
| Models, Biological | 5 | 2011 | 9505 | 0.040 |
Why?
|
| History, 19th Century | 1 | 2003 | 716 | 0.040 |
Why?
|
| Genetic Linkage | 3 | 2005 | 2342 | 0.040 |
Why?
|
| Simvastatin | 1 | 2023 | 346 | 0.040 |
Why?
|
| Pheochromocytoma | 3 | 1980 | 328 | 0.040 |
Why?
|
| Endothelial Cells | 2 | 2011 | 3586 | 0.040 |
Why?
|
| Chlorides | 3 | 1981 | 663 | 0.040 |
Why?
|
| Adrenergic alpha-Agonists | 1 | 2001 | 177 | 0.040 |
Why?
|
| Nutritional Status | 2 | 2020 | 1623 | 0.040 |
Why?
|
| Benzimidazoles | 3 | 2004 | 864 | 0.040 |
Why?
|
| Epinephrine | 5 | 2010 | 795 | 0.040 |
Why?
|
| Fibrinolysis | 3 | 2001 | 333 | 0.040 |
Why?
|
| Cholesterol Side-Chain Cleavage Enzyme | 2 | 1993 | 28 | 0.040 |
Why?
|
| Regression Analysis | 6 | 2012 | 6353 | 0.040 |
Why?
|
| Epidemiology | 1 | 2003 | 280 | 0.040 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 1984 | 1438 | 0.040 |
Why?
|
| Adrenalectomy | 6 | 2000 | 348 | 0.040 |
Why?
|
| Muscle, Smooth | 2 | 1974 | 930 | 0.040 |
Why?
|
| Cough | 1 | 2004 | 598 | 0.040 |
Why?
|
| Cardiac Output | 2 | 2002 | 838 | 0.040 |
Why?
|
| Osmolar Concentration | 5 | 2004 | 659 | 0.040 |
Why?
|
| Diuresis | 3 | 1982 | 106 | 0.040 |
Why?
|
| Sensitivity and Specificity | 5 | 2003 | 14728 | 0.040 |
Why?
|
| Thiazolidinediones | 1 | 2003 | 462 | 0.040 |
Why?
|
| Rabbits | 6 | 2011 | 4786 | 0.040 |
Why?
|
| Muscle Cramp | 1 | 1999 | 34 | 0.040 |
Why?
|
| Parathyroid Glands | 2 | 2013 | 522 | 0.040 |
Why?
|
| Peritoneal Dialysis | 2 | 1998 | 160 | 0.040 |
Why?
|
| Tilt-Table Test | 3 | 2005 | 80 | 0.040 |
Why?
|
| Receptors, Drug | 2 | 1976 | 157 | 0.040 |
Why?
|
| Tamoxifen | 1 | 2004 | 968 | 0.040 |
Why?
|
| Homovanillic Acid | 1 | 1999 | 75 | 0.040 |
Why?
|
| Polyuria | 1 | 1999 | 37 | 0.040 |
Why?
|
| Secretory Rate | 6 | 1976 | 81 | 0.040 |
Why?
|
| Hydrogen-Ion Concentration | 5 | 2002 | 2488 | 0.040 |
Why?
|
| Prognosis | 7 | 2020 | 30028 | 0.040 |
Why?
|
| Tritium | 8 | 1974 | 707 | 0.040 |
Why?
|
| Dexamethasone | 7 | 1985 | 1965 | 0.040 |
Why?
|
| Ultrasonography | 1 | 2012 | 5995 | 0.040 |
Why?
|
| Adrenal Insufficiency | 3 | 1978 | 194 | 0.040 |
Why?
|
| Antibody Specificity | 3 | 2000 | 1065 | 0.040 |
Why?
|
| Administration, Intravaginal | 1 | 1999 | 149 | 0.040 |
Why?
|
| Pituitary Gland | 3 | 1978 | 634 | 0.040 |
Why?
|
| Inositol 1,4,5-Trisphosphate | 2 | 1989 | 110 | 0.040 |
Why?
|
| Activities of Daily Living | 1 | 1988 | 2433 | 0.040 |
Why?
|
| Endolymphatic Hydrops | 1 | 2018 | 31 | 0.040 |
Why?
|
| Ammonia | 2 | 1976 | 249 | 0.040 |
Why?
|
| Fibrinogen | 1 | 2002 | 892 | 0.040 |
Why?
|
| Fibrin | 1 | 2021 | 515 | 0.040 |
Why?
|
| Protein Kinase C | 2 | 1995 | 1207 | 0.040 |
Why?
|
| Sella Turcica | 2 | 1978 | 117 | 0.040 |
Why?
|
| Diuretics | 4 | 2013 | 612 | 0.040 |
Why?
|
| Treatment Outcome | 9 | 2012 | 65409 | 0.040 |
Why?
|
| Calcium-Binding Proteins | 1 | 1983 | 1085 | 0.040 |
Why?
|
| Tetrahydroisoquinolines | 1 | 1998 | 81 | 0.040 |
Why?
|
| Dialysis Solutions | 1 | 1998 | 34 | 0.040 |
Why?
|
| DNA | 1 | 2012 | 7213 | 0.040 |
Why?
|
| Mibefradil | 1 | 1998 | 5 | 0.040 |
Why?
|
| Endolymphatic Sac | 1 | 2018 | 49 | 0.040 |
Why?
|
| Follow-Up Studies | 6 | 2020 | 39430 | 0.040 |
Why?
|
| Amino Acid Sequence | 1 | 2010 | 13452 | 0.040 |
Why?
|
| Dihydropyridines | 1 | 1998 | 67 | 0.040 |
Why?
|
| Animal Nutritional Physiological Phenomena | 1 | 2017 | 56 | 0.040 |
Why?
|
| Bayes Theorem | 1 | 2006 | 2358 | 0.040 |
Why?
|
| Liver Cirrhosis, Alcoholic | 1 | 1977 | 64 | 0.040 |
Why?
|
| Thirst | 1 | 1997 | 42 | 0.040 |
Why?
|
| Tetrahydronaphthalenes | 1 | 1998 | 86 | 0.040 |
Why?
|
| ACTH Syndrome, Ectopic | 2 | 1992 | 30 | 0.040 |
Why?
|
| Adipose Tissue | 4 | 2016 | 3335 | 0.040 |
Why?
|
| Delayed-Action Preparations | 3 | 2003 | 969 | 0.040 |
Why?
|
| Electrolytes | 4 | 1989 | 278 | 0.040 |
Why?
|
| Mutation | 5 | 2020 | 30243 | 0.040 |
Why?
|
| Nicotinamide Phosphoribosyltransferase | 1 | 2017 | 85 | 0.040 |
Why?
|
| Blood Vessels | 3 | 1982 | 1112 | 0.040 |
Why?
|
| Hematocrit | 5 | 1993 | 625 | 0.040 |
Why?
|
| Blood Pressure Monitoring, Ambulatory | 1 | 1999 | 252 | 0.040 |
Why?
|
| Immune Sera | 2 | 1994 | 605 | 0.040 |
Why?
|
| Binding, Competitive | 3 | 1988 | 1144 | 0.030 |
Why?
|
| Blood Urea Nitrogen | 4 | 1983 | 187 | 0.030 |
Why?
|
| Isoquinolines | 1 | 1998 | 354 | 0.030 |
Why?
|
| Endocrinology | 1 | 2003 | 443 | 0.030 |
Why?
|
| Penile Erection | 1 | 1997 | 101 | 0.030 |
Why?
|
| Gynecomastia | 1 | 1977 | 88 | 0.030 |
Why?
|
| Administration, Cutaneous | 1 | 1999 | 716 | 0.030 |
Why?
|
| Depressive Disorder | 2 | 2000 | 3738 | 0.030 |
Why?
|
| Aldehyde Reductase | 1 | 2016 | 70 | 0.030 |
Why?
|
| Syndrome | 3 | 1997 | 3278 | 0.030 |
Why?
|
| Tachycardia | 1 | 1999 | 599 | 0.030 |
Why?
|
| Hypokalemia | 3 | 1992 | 153 | 0.030 |
Why?
|
| United States | 6 | 2023 | 73121 | 0.030 |
Why?
|
| Chromatography, Paper | 4 | 1987 | 76 | 0.030 |
Why?
|
| Base Sequence | 3 | 2002 | 12428 | 0.030 |
Why?
|
| Students, Medical | 1 | 2010 | 1962 | 0.030 |
Why?
|
| Losartan | 2 | 1997 | 263 | 0.030 |
Why?
|
| Electric Conductivity | 2 | 1987 | 408 | 0.030 |
Why?
|
| Angina Pectoris | 1 | 2000 | 960 | 0.030 |
Why?
|
| Retinol-Binding Proteins, Plasma | 1 | 2016 | 94 | 0.030 |
Why?
|
| Hypoglycemic Agents | 2 | 2013 | 3111 | 0.030 |
Why?
|
| Gallic Acid | 2 | 1986 | 25 | 0.030 |
Why?
|
| Penis | 1 | 1997 | 213 | 0.030 |
Why?
|
| Oligonucleotide Probes | 1 | 1996 | 417 | 0.030 |
Why?
|
| Pituitary Neoplasms | 2 | 1982 | 1325 | 0.030 |
Why?
|
| Medical Records | 2 | 1999 | 1413 | 0.030 |
Why?
|
| Depression, Chemical | 4 | 1979 | 186 | 0.030 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2005 | 2258 | 0.030 |
Why?
|
| Cold Temperature | 1 | 1999 | 786 | 0.030 |
Why?
|
| Endothelium, Vascular | 2 | 2013 | 4425 | 0.030 |
Why?
|
| False Negative Reactions | 1 | 2016 | 575 | 0.030 |
Why?
|
| Thiazoles | 1 | 2003 | 1541 | 0.030 |
Why?
|
| Buffers | 3 | 1992 | 144 | 0.030 |
Why?
|
| History, 20th Century | 1 | 2003 | 2772 | 0.030 |
Why?
|
| Digitoxin | 1 | 1994 | 19 | 0.030 |
Why?
|
| Severity of Illness Index | 4 | 2020 | 15965 | 0.030 |
Why?
|
| Hypertension, Renovascular | 3 | 1980 | 115 | 0.030 |
Why?
|
| Health Services Needs and Demand | 1 | 2003 | 1408 | 0.030 |
Why?
|
| Prospective Studies | 5 | 2023 | 54914 | 0.030 |
Why?
|
| Data Interpretation, Statistical | 2 | 2002 | 2705 | 0.030 |
Why?
|
| Protein Binding | 4 | 2014 | 9376 | 0.030 |
Why?
|
| Adrenocortical Hyperfunction | 2 | 1971 | 13 | 0.030 |
Why?
|
| Demography | 1 | 1999 | 1643 | 0.030 |
Why?
|
| beta-Endorphin | 2 | 1985 | 43 | 0.030 |
Why?
|
| Recovery of Function | 1 | 2005 | 2994 | 0.030 |
Why?
|
| Family | 1 | 2005 | 3208 | 0.030 |
Why?
|
| Constipation | 1 | 1999 | 570 | 0.030 |
Why?
|
| U937 Cells | 1 | 2014 | 260 | 0.030 |
Why?
|
| Pregnancy Trimester, Second | 1 | 1997 | 738 | 0.030 |
Why?
|
| Nuclear Family | 3 | 2001 | 311 | 0.030 |
Why?
|
| Adenoma | 4 | 1978 | 2163 | 0.030 |
Why?
|
| Steroid 11-beta-Hydroxylase | 1 | 1993 | 20 | 0.030 |
Why?
|
| Temporal Bone | 1 | 2018 | 683 | 0.030 |
Why?
|
| Furosemide | 4 | 1985 | 171 | 0.030 |
Why?
|
| Chemoreceptor Cells | 1 | 1974 | 88 | 0.030 |
Why?
|
| Acidosis | 1 | 1976 | 271 | 0.030 |
Why?
|
| Logistic Models | 2 | 2005 | 13324 | 0.030 |
Why?
|
| NAD | 1 | 2017 | 618 | 0.030 |
Why?
|
| HEK293 Cells | 2 | 2014 | 4294 | 0.030 |
Why?
|
| Hemodialysis Solutions | 1 | 1993 | 7 | 0.030 |
Why?
|
| Heart Injuries | 1 | 2015 | 207 | 0.030 |
Why?
|
| Hyperinsulinism | 1 | 1996 | 401 | 0.030 |
Why?
|
| Spectrophotometry | 3 | 1988 | 292 | 0.030 |
Why?
|
| Cardenolides | 4 | 1994 | 17 | 0.030 |
Why?
|
| Pregnancy | 10 | 1997 | 30179 | 0.030 |
Why?
|
| Light | 1 | 1999 | 1357 | 0.030 |
Why?
|
| Isoenzymes | 1 | 1998 | 1685 | 0.030 |
Why?
|
| Prazosin | 3 | 1981 | 95 | 0.030 |
Why?
|
| Dermatoglyphics | 1 | 1972 | 21 | 0.030 |
Why?
|
| Multigene Family | 1 | 1996 | 1081 | 0.030 |
Why?
|
| Body Fluids | 1 | 1994 | 322 | 0.030 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 1995 | 484 | 0.030 |
Why?
|
| Reproducibility of Results | 3 | 2010 | 20231 | 0.030 |
Why?
|
| Blood Flow Velocity | 1 | 1996 | 1377 | 0.030 |
Why?
|
| Lymphocytes | 2 | 1996 | 2611 | 0.030 |
Why?
|
| Psychotic Disorders | 2 | 2006 | 3278 | 0.030 |
Why?
|
| Systole | 2 | 2006 | 938 | 0.030 |
Why?
|
| Cesium | 1 | 1992 | 36 | 0.030 |
Why?
|
| Renal Insufficiency | 1 | 1998 | 809 | 0.030 |
Why?
|
| Barium | 1 | 1992 | 62 | 0.030 |
Why?
|
| Turner Syndrome | 2 | 1974 | 130 | 0.030 |
Why?
|
| Fluorescent Dyes | 3 | 1990 | 1924 | 0.030 |
Why?
|
| Heart Ventricles | 1 | 2004 | 3839 | 0.030 |
Why?
|
| Xenopus | 1 | 2014 | 710 | 0.030 |
Why?
|
| Steroid 17-alpha-Hydroxylase | 1 | 1992 | 99 | 0.030 |
Why?
|
| Nadolol | 1 | 1992 | 29 | 0.020 |
Why?
|
| Vascular Diseases | 1 | 2000 | 1162 | 0.020 |
Why?
|
| Lipoproteins, HDL | 1 | 2016 | 682 | 0.020 |
Why?
|
| Caveolin 3 | 1 | 2011 | 24 | 0.020 |
Why?
|
| 4-Aminopyridine | 1 | 1992 | 81 | 0.020 |
Why?
|
| Ion Channels | 2 | 1987 | 1044 | 0.020 |
Why?
|
| Nucleic Acid Conformation | 1 | 2015 | 899 | 0.020 |
Why?
|
| 11-beta-Hydroxysteroid Dehydrogenase Type 2 | 1 | 2011 | 18 | 0.020 |
Why?
|
| Periodicals as Topic | 1 | 2003 | 1468 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2014 | 876 | 0.020 |
Why?
|
| Molecular Biology | 1 | 1995 | 573 | 0.020 |
Why?
|
| Validation Studies as Topic | 1 | 2012 | 162 | 0.020 |
Why?
|
| Pregnancy in Diabetics | 1 | 1993 | 198 | 0.020 |
Why?
|
| Metyrapone | 2 | 1990 | 22 | 0.020 |
Why?
|
| Prolactin | 2 | 1983 | 626 | 0.020 |
Why?
|
| Hydrogen | 1 | 1992 | 172 | 0.020 |
Why?
|
| Adrenergic beta-Agonists | 3 | 2000 | 347 | 0.020 |
Why?
|
| Homozygote | 1 | 1996 | 1779 | 0.020 |
Why?
|
| Cycloheximide | 3 | 2000 | 343 | 0.020 |
Why?
|
| Oxidoreductases | 1 | 1973 | 412 | 0.020 |
Why?
|
| Intracellular Membranes | 1 | 1992 | 388 | 0.020 |
Why?
|
| Coronary Artery Disease | 1 | 2010 | 6551 | 0.020 |
Why?
|
| Waist-Hip Ratio | 1 | 2012 | 520 | 0.020 |
Why?
|
| Testis | 2 | 1974 | 783 | 0.020 |
Why?
|
| Fetal Death | 1 | 1972 | 438 | 0.020 |
Why?
|
| Blotting, Northern | 1 | 1992 | 1553 | 0.020 |
Why?
|
| Microscopy, Electron | 1 | 2014 | 2565 | 0.020 |
Why?
|
| Acetylcholine | 2 | 2010 | 629 | 0.020 |
Why?
|
| Postprandial Period | 1 | 2012 | 319 | 0.020 |
Why?
|
| Hypopituitarism | 3 | 1972 | 251 | 0.020 |
Why?
|
| Adenosine Diphosphate | 2 | 1988 | 423 | 0.020 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2013 | 598 | 0.020 |
Why?
|
| Estrogen Receptor alpha | 1 | 2014 | 582 | 0.020 |
Why?
|
| Dinoprostone | 2 | 1984 | 597 | 0.020 |
Why?
|
| Aged, 80 and over | 4 | 2006 | 59680 | 0.020 |
Why?
|
| Aorta, Thoracic | 2 | 2011 | 1107 | 0.020 |
Why?
|
| Child | 6 | 2017 | 80863 | 0.020 |
Why?
|
| Fatty Acid Desaturases | 1 | 2010 | 102 | 0.020 |
Why?
|
| Feedback, Physiological | 1 | 2012 | 480 | 0.020 |
Why?
|
| Abetalipoproteinemia | 1 | 1969 | 16 | 0.020 |
Why?
|
| Cross-Over Studies | 3 | 2004 | 2103 | 0.020 |
Why?
|
| Cell Membrane | 2 | 2011 | 3664 | 0.020 |
Why?
|
| Methods | 4 | 1975 | 1067 | 0.020 |
Why?
|
| Testosterone | 8 | 1977 | 2493 | 0.020 |
Why?
|
| TCF Transcription Factors | 1 | 2010 | 138 | 0.020 |
Why?
|
| Risk Assessment | 3 | 2017 | 24311 | 0.020 |
Why?
|
| Transcription Factor 7-Like 2 Protein | 1 | 2010 | 152 | 0.020 |
Why?
|
| Cosyntropin | 3 | 1998 | 34 | 0.020 |
Why?
|
| Antibodies | 3 | 1991 | 2425 | 0.020 |
Why?
|
| Rats, Inbred SHR | 1 | 1989 | 187 | 0.020 |
Why?
|
| Retrospective Studies | 5 | 2016 | 81834 | 0.020 |
Why?
|
| Health Status Indicators | 1 | 1994 | 971 | 0.020 |
Why?
|
| Texas | 1 | 2010 | 405 | 0.020 |
Why?
|
| Incretins | 1 | 2010 | 100 | 0.020 |
Why?
|
| Coronary Vessels | 1 | 2000 | 3122 | 0.020 |
Why?
|
| Vitamin D | 2 | 2013 | 3311 | 0.020 |
Why?
|
| Microchemistry | 1 | 1988 | 55 | 0.020 |
Why?
|
| Autoanalysis | 2 | 1987 | 70 | 0.020 |
Why?
|
| Platelet Count | 2 | 1988 | 786 | 0.020 |
Why?
|
| Coronary Disease | 1 | 2003 | 5926 | 0.020 |
Why?
|
| Psychiatric Status Rating Scales | 3 | 2006 | 6035 | 0.020 |
Why?
|
| Isomerism | 1 | 1988 | 198 | 0.020 |
Why?
|
| Protein Kinase C-delta | 1 | 2008 | 115 | 0.020 |
Why?
|
| Ovarian Cysts | 1 | 1969 | 108 | 0.020 |
Why?
|
| Nitroprusside | 2 | 1986 | 272 | 0.020 |
Why?
|
| Saphenous Vein | 1 | 2011 | 519 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2012 | 1640 | 0.020 |
Why?
|
| Pedigree | 1 | 1996 | 4545 | 0.020 |
Why?
|
| Life Style | 2 | 2012 | 3929 | 0.020 |
Why?
|
| Polycystic Ovary Syndrome | 1 | 1972 | 383 | 0.020 |
Why?
|
| 3T3-L1 Cells | 1 | 2008 | 208 | 0.020 |
Why?
|
| Monitoring, Physiologic | 2 | 2000 | 1795 | 0.020 |
Why?
|
| Phosphatidylinositol Phosphates | 1 | 1988 | 201 | 0.020 |
Why?
|
| Cholecalciferol | 1 | 2012 | 557 | 0.020 |
Why?
|
| Isometric Contraction | 1 | 2008 | 150 | 0.020 |
Why?
|
| Enzyme Activation | 3 | 1995 | 3594 | 0.020 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2012 | 797 | 0.020 |
Why?
|
| Denmark | 1 | 2010 | 778 | 0.020 |
Why?
|
| Incidence | 3 | 2013 | 21552 | 0.020 |
Why?
|
| Sodium Channels | 1 | 1989 | 341 | 0.020 |
Why?
|
| Serum Albumin, Bovine | 3 | 1973 | 320 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2014 | 3790 | 0.020 |
Why?
|
| Abortion, Spontaneous | 1 | 1972 | 539 | 0.020 |
Why?
|
| Pituitary-Adrenal Function Tests | 4 | 1974 | 30 | 0.020 |
Why?
|
| Dogs | 4 | 1998 | 3847 | 0.020 |
Why?
|
| Models, Cardiovascular | 2 | 2003 | 986 | 0.020 |
Why?
|
| Cations, Divalent | 1 | 1987 | 167 | 0.020 |
Why?
|
| Species Specificity | 3 | 1991 | 2422 | 0.020 |
Why?
|
| Lanthanum | 1 | 1986 | 30 | 0.020 |
Why?
|
| Dantrolene | 1 | 1986 | 26 | 0.020 |
Why?
|
| Bucladesine | 1 | 1986 | 118 | 0.020 |
Why?
|
| T-Lymphocytes | 1 | 1984 | 10273 | 0.020 |
Why?
|
| Tissue Distribution | 1 | 1991 | 2298 | 0.020 |
Why?
|
| Longitudinal Studies | 2 | 2006 | 14766 | 0.020 |
Why?
|
| Placebos | 1 | 2011 | 1668 | 0.020 |
Why?
|
| Carotid Arteries | 1 | 2011 | 943 | 0.020 |
Why?
|
| Angiotensin Receptor Antagonists | 2 | 2007 | 1066 | 0.020 |
Why?
|
| Demyelinating Diseases | 1 | 1969 | 359 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2015 | 2465 | 0.020 |
Why?
|
| Cations | 1 | 1987 | 240 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2004 | 36840 | 0.020 |
Why?
|
| Aminoquinolines | 1 | 1986 | 105 | 0.020 |
Why?
|
| Ferricyanides | 1 | 1986 | 31 | 0.020 |
Why?
|
| Solutions | 1 | 1987 | 411 | 0.020 |
Why?
|
| Hirsutism | 3 | 1977 | 68 | 0.020 |
Why?
|
| Phosphoproteins | 1 | 1995 | 2450 | 0.020 |
Why?
|
| Streptozocin | 1 | 2006 | 195 | 0.020 |
Why?
|
| Hypertrophy | 2 | 2006 | 562 | 0.020 |
Why?
|
| Evoked Potentials | 1 | 1992 | 1057 | 0.020 |
Why?
|
| Metformin | 1 | 2013 | 914 | 0.020 |
Why?
|
| Microelectrodes | 1 | 1987 | 308 | 0.020 |
Why?
|
| Sheep | 3 | 1973 | 1451 | 0.020 |
Why?
|
| South Dakota | 1 | 2005 | 32 | 0.020 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2013 | 1969 | 0.020 |
Why?
|
| Mathematics | 1 | 1987 | 704 | 0.020 |
Why?
|
| Phosphates | 1 | 1989 | 767 | 0.020 |
Why?
|
| Death, Sudden | 1 | 1987 | 301 | 0.020 |
Why?
|
| Cell Membrane Permeability | 1 | 1987 | 574 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2015 | 5443 | 0.020 |
Why?
|
| Internationality | 1 | 2010 | 1007 | 0.020 |
Why?
|
| Egtazic Acid | 1 | 1985 | 166 | 0.020 |
Why?
|
| Mice, Mutant Strains | 1 | 2008 | 1755 | 0.010 |
Why?
|
| Statistical Distributions | 1 | 2004 | 63 | 0.010 |
Why?
|
| Founder Effect | 1 | 2005 | 185 | 0.010 |
Why?
|
| Biological Transport | 1 | 1989 | 2089 | 0.010 |
Why?
|
| Patient Dropouts | 1 | 1987 | 411 | 0.010 |
Why?
|
| Osteopontin | 1 | 2006 | 307 | 0.010 |
Why?
|
| Public Health | 1 | 1998 | 2693 | 0.010 |
Why?
|
| Quinazolines | 2 | 1981 | 1376 | 0.010 |
Why?
|
| Fluorescence | 1 | 1987 | 760 | 0.010 |
Why?
|
| Diagnosis, Differential | 6 | 2000 | 13026 | 0.010 |
Why?
|
| Chemistry | 1 | 1984 | 327 | 0.010 |
Why?
|
| Isotope Labeling | 1 | 1985 | 395 | 0.010 |
Why?
|
| Chemical Phenomena | 1 | 1984 | 486 | 0.010 |
Why?
|
| Kininogens | 1 | 1983 | 15 | 0.010 |
Why?
|
| Benzazepines | 1 | 1986 | 311 | 0.010 |
Why?
|
| Central Nervous System | 1 | 1991 | 1348 | 0.010 |
Why?
|
| Angiotensin III | 1 | 1983 | 1 | 0.010 |
Why?
|
| 1-Sarcosine-8-Isoleucine Angiotensin II | 1 | 1983 | 3 | 0.010 |
Why?
|
| Gonadotropins | 4 | 1974 | 241 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 1990 | 2640 | 0.010 |
Why?
|
| Administration, Oral | 2 | 1990 | 4041 | 0.010 |
Why?
|
| Parasympathetic Nervous System | 1 | 2003 | 144 | 0.010 |
Why?
|
| Immunohistochemistry | 2 | 2011 | 11138 | 0.010 |
Why?
|
| Ultracentrifugation | 1 | 2003 | 182 | 0.010 |
Why?
|
| Cardiomyopathies | 2 | 2000 | 2056 | 0.010 |
Why?
|
| Edetic Acid | 1 | 1983 | 278 | 0.010 |
Why?
|
| Space Flight | 1 | 2005 | 218 | 0.010 |
Why?
|
| Databases, Genetic | 1 | 2010 | 1750 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 1996 | 7599 | 0.010 |
Why?
|
| Cytokines | 1 | 2017 | 7449 | 0.010 |
Why?
|
| Tetradecanoylphorbol Acetate | 2 | 1995 | 826 | 0.010 |
Why?
|
| Algorithms | 2 | 2016 | 14158 | 0.010 |
Why?
|
| Chromosome Mapping | 1 | 2010 | 4622 | 0.010 |
Why?
|
| Hyperplasia | 2 | 1978 | 1154 | 0.010 |
Why?
|
| Biological Assay | 3 | 1974 | 629 | 0.010 |
Why?
|
| Carbon Isotopes | 2 | 1973 | 459 | 0.010 |
Why?
|
| Polymorphism, Single-Stranded Conformational | 1 | 2002 | 326 | 0.010 |
Why?
|
| France | 1 | 2003 | 497 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2021 | 12174 | 0.010 |
Why?
|
| Dextrans | 2 | 1993 | 574 | 0.010 |
Why?
|
| Amiloride | 2 | 1993 | 116 | 0.010 |
Why?
|
| Extracellular Space | 1 | 1983 | 565 | 0.010 |
Why?
|
| Electric Stimulation | 1 | 1987 | 1743 | 0.010 |
Why?
|
| Age of Onset | 1 | 2009 | 3342 | 0.010 |
Why?
|
| Electrocardiography | 2 | 2005 | 6410 | 0.010 |
Why?
|
| Catheters, Indwelling | 1 | 1984 | 436 | 0.010 |
Why?
|
| Apolipoprotein C-III | 1 | 2003 | 210 | 0.010 |
Why?
|
| Complement System Proteins | 1 | 1984 | 739 | 0.010 |
Why?
|
| Premedication | 1 | 1982 | 246 | 0.010 |
Why?
|
| Enzyme Induction | 2 | 1972 | 455 | 0.010 |
Why?
|
| Receptors, Adrenergic | 1 | 1981 | 155 | 0.010 |
Why?
|
| Triiodothyronine | 1 | 1983 | 492 | 0.010 |
Why?
|
| Health Surveys | 1 | 2011 | 4056 | 0.010 |
Why?
|
| Italy | 1 | 2003 | 853 | 0.010 |
Why?
|
| Ethanolamines | 1 | 1981 | 153 | 0.010 |
Why?
|
| DNA Copy Number Variations | 1 | 2010 | 2046 | 0.010 |
Why?
|
| Karyotyping | 3 | 1974 | 1173 | 0.010 |
Why?
|
| Liver | 1 | 2016 | 7575 | 0.010 |
Why?
|
| Diastole | 1 | 2003 | 784 | 0.010 |
Why?
|
| Cell Separation | 2 | 1992 | 1726 | 0.010 |
Why?
|
| Receptors, Adrenergic, beta | 1 | 1981 | 243 | 0.010 |
Why?
|
| Cross Reactions | 2 | 1973 | 828 | 0.010 |
Why?
|
| Carcinoma | 2 | 1971 | 2341 | 0.010 |
Why?
|
| Radiography | 3 | 1982 | 6995 | 0.010 |
Why?
|
| Homeodomain Proteins | 1 | 2010 | 2430 | 0.010 |
Why?
|
| Menopause | 2 | 2000 | 1651 | 0.010 |
Why?
|
| Hormone Antagonists | 1 | 2000 | 107 | 0.010 |
Why?
|
| Protein Synthesis Inhibitors | 1 | 2000 | 190 | 0.010 |
Why?
|
| Mass Screening | 1 | 2016 | 5455 | 0.010 |
Why?
|
| Tissue Plasminogen Activator | 2 | 1998 | 1166 | 0.010 |
Why?
|
| Nitric Oxide Donors | 1 | 2000 | 126 | 0.010 |
Why?
|
| Dipeptidyl-Peptidases and Tripeptidyl-Peptidases | 1 | 1980 | 88 | 0.010 |
Why?
|
| 18-Hydroxycorticosterone | 1 | 1979 | 3 | 0.010 |
Why?
|
| Adrenal Cortex Function Tests | 1 | 1979 | 12 | 0.010 |
Why?
|
| Autonomic Nervous System | 1 | 2005 | 709 | 0.010 |
Why?
|
| Leptin | 1 | 2008 | 1598 | 0.010 |
Why?
|
| Pulmonary Wedge Pressure | 1 | 1981 | 278 | 0.010 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2010 | 2819 | 0.010 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 1987 | 1496 | 0.010 |
Why?
|
| Binding Sites | 1 | 1988 | 6030 | 0.010 |
Why?
|
| Action Potentials | 1 | 1987 | 1837 | 0.010 |
Why?
|
| Glucagon | 2 | 1972 | 534 | 0.010 |
Why?
|
| Darkness | 1 | 1999 | 160 | 0.010 |
Why?
|
| Cadmium | 1 | 2000 | 216 | 0.010 |
Why?
|
| Chromatography, Liquid | 1 | 2003 | 998 | 0.010 |
Why?
|
| Cyclooxygenase Inhibitors | 1 | 1981 | 361 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 2016 | 7451 | 0.010 |
Why?
|
| Drug Interactions | 1 | 2003 | 1421 | 0.010 |
Why?
|
| Autonomic Nervous System Diseases | 1 | 2001 | 269 | 0.010 |
Why?
|
| Cell Size | 1 | 2000 | 626 | 0.010 |
Why?
|
| Propanolamines | 1 | 1979 | 164 | 0.010 |
Why?
|
| Cell Count | 1 | 1982 | 1835 | 0.010 |
Why?
|
| Prekallikrein | 1 | 1977 | 11 | 0.010 |
Why?
|
| Serotonin | 1 | 1983 | 1047 | 0.010 |
Why?
|
| Renal Artery Obstruction | 1 | 1979 | 218 | 0.010 |
Why?
|
| Delusions | 1 | 2000 | 301 | 0.010 |
Why?
|
| Women's Health | 1 | 2008 | 2079 | 0.010 |
Why?
|
| Hypothalamic Hormones | 1 | 1999 | 145 | 0.010 |
Why?
|
| Osmosis | 1 | 1997 | 103 | 0.010 |
Why?
|
| Mixed Function Oxygenases | 2 | 1977 | 265 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 2003 | 2863 | 0.010 |
Why?
|
| Probability | 1 | 2003 | 2483 | 0.010 |
Why?
|
| Hallucinations | 1 | 2000 | 375 | 0.010 |
Why?
|
| Papaverine | 1 | 1997 | 45 | 0.010 |
Why?
|
| Odds Ratio | 1 | 2010 | 9687 | 0.010 |
Why?
|
| Neurotransmitter Agents | 1 | 1981 | 666 | 0.010 |
Why?
|
| Alprostadil | 1 | 1997 | 86 | 0.010 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 1999 | 882 | 0.010 |
Why?
|
| Exercise Test | 1 | 2005 | 2186 | 0.010 |
Why?
|
| Immunoblotting | 1 | 2000 | 1650 | 0.010 |
Why?
|
| Dysgerminoma | 2 | 1974 | 66 | 0.010 |
Why?
|
| Sexual Behavior | 1 | 1987 | 2200 | 0.010 |
Why?
|
| Observer Variation | 1 | 2003 | 2622 | 0.010 |
Why?
|
| Statistics as Topic | 1 | 2003 | 2362 | 0.010 |
Why?
|
| Homosexuality | 2 | 1975 | 268 | 0.010 |
Why?
|
| Pregnanetriol | 2 | 1977 | 4 | 0.010 |
Why?
|
| Adverse Drug Reaction Reporting Systems | 1 | 2000 | 495 | 0.010 |
Why?
|
| False Positive Reactions | 1 | 1979 | 962 | 0.010 |
Why?
|
| Fetal Blood | 2 | 1994 | 1353 | 0.010 |
Why?
|
| Dihydrotestosterone | 2 | 1975 | 195 | 0.010 |
Why?
|
| Image Enhancement | 1 | 1987 | 2894 | 0.010 |
Why?
|
| Aortic Aneurysm | 1 | 1981 | 649 | 0.010 |
Why?
|
| Overweight | 1 | 2007 | 2428 | 0.010 |
Why?
|
| Necrosis | 1 | 2000 | 1621 | 0.010 |
Why?
|
| Body Temperature | 1 | 1999 | 781 | 0.010 |
Why?
|
| Adenofibroma | 1 | 1975 | 25 | 0.010 |
Why?
|
| Microcirculation | 1 | 2000 | 1282 | 0.010 |
Why?
|
| Calcimycin | 1 | 1995 | 214 | 0.010 |
Why?
|
| Mastitis | 1 | 1975 | 43 | 0.010 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 1995 | 284 | 0.010 |
Why?
|
| Methoxyhydroxyphenylglycol | 1 | 1994 | 93 | 0.010 |
Why?
|
| Infant | 1 | 2017 | 36497 | 0.010 |
Why?
|
| Proteins | 1 | 2010 | 6008 | 0.010 |
Why?
|
| Sexual Behavior, Animal | 1 | 1975 | 120 | 0.010 |
Why?
|
| Fatty Acids, Nonesterified | 2 | 1993 | 394 | 0.010 |
Why?
|
| Cell Compartmentation | 1 | 1995 | 383 | 0.010 |
Why?
|
| Contraceptives, Oral, Hormonal | 1 | 1976 | 190 | 0.010 |
Why?
|
| Liver Diseases | 2 | 1994 | 1307 | 0.010 |
Why?
|
| Leukocytes | 1 | 1982 | 2030 | 0.010 |
Why?
|
| Virilism | 1 | 1974 | 28 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2017 | 42623 | 0.010 |
Why?
|
| Altitude | 1 | 1975 | 164 | 0.010 |
Why?
|
| Androgen-Insensitivity Syndrome | 1 | 1974 | 33 | 0.010 |
Why?
|
| Hypophysectomy | 2 | 1971 | 114 | 0.010 |
Why?
|
| Injections | 1 | 1997 | 840 | 0.010 |
Why?
|
| Ketosteroids | 1 | 1973 | 3 | 0.010 |
Why?
|
| Iodine Isotopes | 1 | 1973 | 79 | 0.010 |
Why?
|
| Lymphocyte Activation | 1 | 1984 | 5495 | 0.010 |
Why?
|
| Contraceptives, Oral | 1 | 1976 | 562 | 0.010 |
Why?
|
| Chloramphenicol | 1 | 1972 | 67 | 0.010 |
Why?
|
| Hypotension | 1 | 1979 | 888 | 0.010 |
Why?
|
| Plasma Volume | 1 | 1972 | 31 | 0.010 |
Why?
|
| Premenopause | 1 | 1997 | 1039 | 0.010 |
Why?
|
| Blood | 1 | 1975 | 597 | 0.010 |
Why?
|
| Mandelic Acids | 1 | 1972 | 46 | 0.010 |
Why?
|
| Clomiphene | 1 | 1972 | 71 | 0.010 |
Why?
|
| Physical Exertion | 1 | 1975 | 669 | 0.010 |
Why?
|
| Ion Exchange | 1 | 1992 | 16 | 0.010 |
Why?
|
| Mental Disorders | 1 | 1972 | 6879 | 0.010 |
Why?
|
| Oxidative Stress | 1 | 2003 | 3145 | 0.010 |
Why?
|
| Bufanolides | 1 | 1991 | 5 | 0.010 |
Why?
|
| Arousal | 1 | 1998 | 1182 | 0.010 |
Why?
|
| Phorbol 12,13-Dibutyrate | 1 | 1991 | 40 | 0.010 |
Why?
|
| Genome, Human | 1 | 2005 | 4453 | 0.010 |
Why?
|
| Genetic Testing | 1 | 2005 | 3586 | 0.010 |
Why?
|
| Chloride-Bicarbonate Antiporters | 1 | 1992 | 103 | 0.010 |
Why?
|
| Echocardiography | 1 | 2004 | 5043 | 0.010 |
Why?
|
| Anions | 1 | 1992 | 138 | 0.010 |
Why?
|
| Amenorrhea | 2 | 1974 | 484 | 0.010 |
Why?
|
| Diabetic Ketoacidosis | 1 | 1975 | 255 | 0.010 |
Why?
|
| Diabetes Complications | 1 | 1978 | 1322 | 0.010 |
Why?
|
| Carbon Dioxide | 2 | 1992 | 1152 | 0.010 |
Why?
|
| Acids | 1 | 1992 | 125 | 0.010 |
Why?
|
| Inulin | 1 | 1991 | 68 | 0.010 |
Why?
|
| Research Design | 1 | 1987 | 6217 | 0.010 |
Why?
|
| Muscle Contraction | 1 | 1976 | 1208 | 0.010 |
Why?
|
| Infusion Pumps | 1 | 1992 | 163 | 0.010 |
Why?
|
| Sodium Radioisotopes | 1 | 1990 | 6 | 0.010 |
Why?
|
| Drug Contamination | 1 | 1972 | 152 | 0.010 |
Why?
|
| Bicarbonates | 1 | 1992 | 292 | 0.010 |
Why?
|
| Antibody Affinity | 1 | 1991 | 252 | 0.010 |
Why?
|
| Vasopressins | 1 | 1972 | 353 | 0.010 |
Why?
|
| Hyperthyroidism | 1 | 1973 | 295 | 0.010 |
Why?
|
| Nephrectomy | 2 | 1973 | 949 | 0.010 |
Why?
|
| Teriparatide | 1 | 1992 | 226 | 0.010 |
Why?
|
| Culture Media | 1 | 1972 | 899 | 0.010 |
Why?
|
| Bloodletting | 1 | 1970 | 22 | 0.010 |
Why?
|
| Coronary Thrombosis | 1 | 1993 | 440 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2003 | 10125 | 0.010 |
Why?
|
| Fluoresceins | 1 | 1990 | 236 | 0.010 |
Why?
|
| Bronchitis | 1 | 1971 | 196 | 0.010 |
Why?
|
| Photometry | 1 | 1970 | 57 | 0.010 |
Why?
|
| Animals, Newborn | 1 | 1975 | 2696 | 0.010 |
Why?
|
| Immunoelectrophoresis | 1 | 1969 | 94 | 0.010 |
Why?
|
| Immunodiffusion | 1 | 1969 | 141 | 0.010 |
Why?
|
| Basal Metabolism | 1 | 1970 | 163 | 0.010 |
Why?
|
| Sex Chromatin | 1 | 1969 | 19 | 0.010 |
Why?
|
| Affective Symptoms | 1 | 1972 | 418 | 0.010 |
Why?
|
| Ambulatory Care | 1 | 2000 | 2780 | 0.010 |
Why?
|
| Aspirin | 1 | 1981 | 3139 | 0.010 |
Why?
|
| Prednisone | 2 | 1971 | 1568 | 0.000 |
Why?
|
| Cytophotometry | 1 | 1988 | 8 | 0.000 |
Why?
|
| Erythrocytes, Abnormal | 1 | 1969 | 121 | 0.000 |
Why?
|
| Emotions | 1 | 1981 | 2773 | 0.000 |
Why?
|
| Hypoglycemia | 2 | 1972 | 894 | 0.000 |
Why?
|
| Fetus | 1 | 1975 | 1883 | 0.000 |
Why?
|
| Injections, Intravenous | 3 | 1980 | 1379 | 0.000 |
Why?
|
| Antibodies, Monoclonal | 1 | 1984 | 9263 | 0.000 |
Why?
|
| Congenital Abnormalities | 1 | 1972 | 708 | 0.000 |
Why?
|
| Androgens | 1 | 1974 | 1285 | 0.000 |
Why?
|
| Jejunum | 1 | 1969 | 475 | 0.000 |
Why?
|
| Clinical Protocols | 1 | 1993 | 1444 | 0.000 |
Why?
|
| Anesthesia, Local | 1 | 1969 | 278 | 0.000 |
Why?
|
| Testicular Neoplasms | 1 | 1973 | 806 | 0.000 |
Why?
|
| Chromosome Disorders | 1 | 1969 | 499 | 0.000 |
Why?
|
| Adenocarcinoma | 2 | 1975 | 6400 | 0.000 |
Why?
|
| Smoking | 1 | 2003 | 9099 | 0.000 |
Why?
|
| Chorionic Gonadotropin | 1 | 1968 | 458 | 0.000 |
Why?
|
| Hippurates | 1 | 1985 | 15 | 0.000 |
Why?
|
| Anesthesia | 1 | 1997 | 1596 | 0.000 |
Why?
|
| Succinimides | 1 | 1985 | 83 | 0.000 |
Why?
|
| Phospholipids | 1 | 1969 | 783 | 0.000 |
Why?
|
| Time | 1 | 1987 | 546 | 0.000 |
Why?
|
| Data Collection | 1 | 1994 | 3329 | 0.000 |
Why?
|
| Androstenedione | 2 | 1975 | 132 | 0.000 |
Why?
|
| Sarcoidosis | 1 | 1971 | 539 | 0.000 |
Why?
|
| Trypsin | 1 | 1985 | 494 | 0.000 |
Why?
|
| Vitamin E | 1 | 1969 | 873 | 0.000 |
Why?
|
| Postpartum Period | 1 | 1992 | 1197 | 0.000 |
Why?
|
| Lithium | 1 | 1988 | 600 | 0.000 |
Why?
|
| Liver Circulation | 1 | 1984 | 159 | 0.000 |
Why?
|
| Chromatography, Affinity | 1 | 1985 | 525 | 0.000 |
Why?
|
| Lipoproteins | 1 | 1969 | 880 | 0.000 |
Why?
|
| Renal Dialysis | 1 | 1973 | 1802 | 0.000 |
Why?
|
| Carbon Radioisotopes | 2 | 1975 | 565 | 0.000 |
Why?
|
| Feces | 1 | 1970 | 1515 | 0.000 |
Why?
|
| Chromosome Aberrations | 1 | 1969 | 1781 | 0.000 |
Why?
|
| Iodine Radioisotopes | 1 | 1985 | 1035 | 0.000 |
Why?
|
| Phenoxybenzamine | 1 | 1981 | 53 | 0.000 |
Why?
|
| Phentolamine | 1 | 1981 | 102 | 0.000 |
Why?
|
| Hydralazine | 1 | 1981 | 34 | 0.000 |
Why?
|
| Receptors, Adrenergic, alpha | 1 | 1981 | 146 | 0.000 |
Why?
|
| Parasympatholytics | 1 | 1981 | 89 | 0.000 |
Why?
|
| Constriction | 1 | 1981 | 168 | 0.000 |
Why?
|
| Fatty Acids | 1 | 1969 | 1818 | 0.000 |
Why?
|
| Adrenergic alpha-Antagonists | 1 | 1981 | 174 | 0.000 |
Why?
|
| Prostaglandins F | 1 | 1980 | 80 | 0.000 |
Why?
|
| Neoplasm Metastasis | 1 | 1971 | 4931 | 0.000 |
Why?
|
| Breast Neoplasms | 2 | 1979 | 21156 | 0.000 |
Why?
|
| Intraoperative Period | 1 | 1981 | 513 | 0.000 |
Why?
|
| Nitrates | 1 | 1981 | 260 | 0.000 |
Why?
|
| Peptide Fragments | 1 | 1992 | 5152 | 0.000 |
Why?
|
| Feminization | 2 | 1969 | 19 | 0.000 |
Why?
|
| Aorta, Abdominal | 1 | 1981 | 627 | 0.000 |
Why?
|
| Intestinal Mucosa | 1 | 1969 | 3048 | 0.000 |
Why?
|
| Sebum | 1 | 1977 | 17 | 0.000 |
Why?
|
| Postoperative Period | 1 | 1981 | 1833 | 0.000 |
Why?
|
| Melanosis | 1 | 1976 | 93 | 0.000 |
Why?
|
| Leydig Cells | 1 | 1974 | 55 | 0.000 |
Why?
|
| Ketosis | 1 | 1975 | 46 | 0.000 |
Why?
|
| Depression | 2 | 1972 | 8235 | 0.000 |
Why?
|
| Aprotinin | 1 | 1975 | 94 | 0.000 |
Why?
|
| Acclimatization | 1 | 1975 | 114 | 0.000 |
Why?
|
| Chronic Disease | 2 | 1981 | 9382 | 0.000 |
Why?
|
| Histocytochemistry | 1 | 1975 | 699 | 0.000 |
Why?
|
| Guinea Pigs | 1 | 1975 | 1310 | 0.000 |
Why?
|
| Clitoris | 1 | 1974 | 35 | 0.000 |
Why?
|
| Progestins | 1 | 1976 | 302 | 0.000 |
Why?
|
| Tolbutamide | 1 | 1972 | 23 | 0.000 |
Why?
|
| Water Intoxication | 1 | 1972 | 10 | 0.000 |
Why?
|
| Chromatography, Ion Exchange | 1 | 1972 | 294 | 0.000 |
Why?
|
| Infant, Newborn | 1 | 1972 | 26395 | 0.000 |
Why?
|
| Diabetes Insipidus | 1 | 1972 | 144 | 0.000 |
Why?
|
| Pituitary Irradiation | 1 | 1970 | 14 | 0.000 |
Why?
|
| Radiation Effects | 1 | 1970 | 73 | 0.000 |
Why?
|
| Puberty | 1 | 1974 | 502 | 0.000 |
Why?
|
| Estriol | 1 | 1969 | 54 | 0.000 |
Why?
|
| Chromatography | 1 | 1969 | 189 | 0.000 |
Why?
|
| Cervix Uteri | 1 | 1974 | 577 | 0.000 |
Why?
|
| Uterus | 1 | 1974 | 660 | 0.000 |
Why?
|
| Pituitary Hormone-Releasing Hormones | 1 | 1969 | 36 | 0.000 |
Why?
|
| Ovary | 1 | 1974 | 960 | 0.000 |
Why?
|
| Hemoglobins | 1 | 1975 | 1532 | 0.000 |
Why?
|
| Psychophysiology | 1 | 1969 | 137 | 0.000 |
Why?
|
| Injections, Subcutaneous | 1 | 1970 | 681 | 0.000 |
Why?
|
| Dehydroepiandrosterone | 1 | 1969 | 259 | 0.000 |
Why?
|
| Respiration | 1 | 1975 | 1667 | 0.000 |
Why?
|
| Phenytoin | 1 | 1969 | 190 | 0.000 |
Why?
|
| Gonadotropins, Pituitary | 1 | 1968 | 69 | 0.000 |
Why?
|
| Pregnancy Tests | 1 | 1968 | 33 | 0.000 |
Why?
|
| Follicle Stimulating Hormone | 1 | 1969 | 726 | 0.000 |
Why?
|
| Metabolism, Inborn Errors | 1 | 1969 | 290 | 0.000 |
Why?
|
| Injections, Intramuscular | 1 | 1968 | 557 | 0.000 |
Why?
|
| Stroke Volume | 1 | 1981 | 5620 | 0.000 |
Why?
|
| Luteinizing Hormone | 1 | 1969 | 821 | 0.000 |
Why?
|
| Gestational Age | 1 | 1975 | 3615 | 0.000 |
Why?
|
| Length of Stay | 1 | 1980 | 6521 | 0.000 |
Why?
|
| Kidney Transplantation | 1 | 1981 | 4285 | 0.000 |
Why?
|
| Hypothalamus | 1 | 1970 | 1004 | 0.000 |
Why?
|
| Psychotherapy | 1 | 1973 | 1656 | 0.000 |
Why?
|
| Oxygen | 1 | 1975 | 4269 | 0.000 |
Why?
|
| Swine | 1 | 1972 | 5996 | 0.000 |
Why?
|
| Postoperative Complications | 1 | 1981 | 15880 | 0.000 |
Why?
|